应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ATRA Atara Biotherapeutics
休市中 12-12 16:00:00 EST
18.00
+0.18
+0.98%
盘后
18.00
+0.00
0.00%
17:58 EST
最高
18.17
最低
16.65
成交量
10.33万
今开
17.82
昨收
17.82
日振幅
8.51%
总市值
1.30亿
流通市值
8,294万
总股本
721.02万
成交额
181.20万
换手率
2.24%
流通股本
460.90万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.11%报13.90美元
市场透视 · 11-21
Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.11%报13.90美元
Atara Biotherapeutics, Inc.2025财年第三财季实现净利润-4.30百万美元,同比增加80.37%
市场透视 · 11-18
Atara Biotherapeutics, Inc.2025财年第三财季实现净利润-4.30百万美元,同比增加80.37%
Atara Biotherapeutics预计2025年全年运营费用将比2024年减少至少60%
美股速递 · 11-12
Atara Biotherapeutics预计2025年全年运营费用将比2024年减少至少60%
Atara Biotherapeutics, Inc.盘中异动 股价大涨10.14%报11.84美元
市场透视 · 11-06
Atara Biotherapeutics, Inc.盘中异动 股价大涨10.14%报11.84美元
Pierre Fabre Pharmaceuticals宣布从Atara Biotherapeutics转让Tabelecleucel治疗EB病毒阳性移植后淋巴增生性疾病的生物许可申请
美股速递 · 11-03
Pierre Fabre Pharmaceuticals宣布从Atara Biotherapeutics转让Tabelecleucel治疗EB病毒阳性移植后淋巴增生性疾病的生物许可申请
Atara Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.84%报14.87美元
市场透视 · 11-01
Atara Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.84%报14.87美元
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌6.36%
市场透视 · 10-21
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌6.36%
Atara Biotherapeutics, Inc.盘中异动 早盘急速上涨5.40%报13.67美元
市场透视 · 09-24
Atara Biotherapeutics, Inc.盘中异动 早盘急速上涨5.40%报13.67美元
Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.32%
市场透视 · 08-20
Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.32%
Atara Biotherapeutics, Inc.盘中异动 急速下挫5.45%报11.62美元
市场透视 · 08-18
Atara Biotherapeutics, Inc.盘中异动 急速下挫5.45%报11.62美元
Atara Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.52%报10.35美元
市场透视 · 08-12
Atara Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.52%报10.35美元
Atara Biotherapeutics, Inc.盘中异动 股价大跌5.05%报10.81美元
市场透视 · 08-08
Atara Biotherapeutics, Inc.盘中异动 股价大跌5.05%报10.81美元
Atara Biotherapeutics, Inc.盘中异动 临近收盘股价大跌5.04%
市场透视 · 08-01
Atara Biotherapeutics, Inc.盘中异动 临近收盘股价大跌5.04%
Atara Biotherapeutics, Inc.盘中异动 大幅拉升5.20%报12.34美元
市场透视 · 07-30
Atara Biotherapeutics, Inc.盘中异动 大幅拉升5.20%报12.34美元
Atara Biotherapeutics, Inc.盘中异动 大幅下挫6.22%
市场透视 · 07-28
Atara Biotherapeutics, Inc.盘中异动 大幅下挫6.22%
Atara Biotherapeutics, Inc.盘中异动 早盘大幅跳水8.08%报8.53美元
市场透视 · 07-17
Atara Biotherapeutics, Inc.盘中异动 早盘大幅跳水8.08%报8.53美元
Atara Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.70%
市场透视 · 07-16
Atara Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.70%
Atara Biotherapeutics, Inc.盘中异动 股价大涨5.19%报9.03美元
市场透视 · 07-09
Atara Biotherapeutics, Inc.盘中异动 股价大涨5.19%报9.03美元
Atara Biotherapeutics, Inc.盘中异动 股价大涨5.07%报8.20美元
市场透视 · 07-02
Atara Biotherapeutics, Inc.盘中异动 股价大涨5.07%报8.20美元
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.24%报7.60美元
市场透视 · 06-20
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.24%报7.60美元
加载更多
公司概况
公司名称:
Atara Biotherapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。该公司是T细胞免疫疗法的领导者,利用其新型同种异体EB病毒(EBV)T细胞平台为癌症和自身免疫性疾病患者开发转化疗法。
发行价格:
--
{"stockData":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":17.995,"timestamp":1765573200000,"preClose":17.82,"halted":0,"volume":103345,"hourTrading":{"tag":"盘后","latestPrice":17.995,"preClose":17.995,"latestTime":"17:58 EST","volume":120,"amount":2173.1859,"timestamp":1765580335064},"delay":0,"floatShares":4609000,"shares":7210235,"eps":0.56325,"marketStatus":"休市中","change":0.175,"latestTime":"12-12 16:00:00 EST","open":17.82,"high":18.1664,"low":16.65,"amount":1811999.454155,"amplitude":0.085095,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.56325,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1413432000000,"exchange":"NASDAQ","adjPreClose":17.82,"preHourTrading":{"tag":"盘前","latestPrice":18.3222,"preClose":17.82,"latestTime":"08:16 EST","volume":26,"amount":472.57220400000006,"timestamp":1765545371208},"postHourTrading":{"tag":"盘后","latestPrice":17.995,"preClose":17.995,"latestTime":"17:58 EST","volume":120,"amount":2173.1859,"timestamp":1765580335064},"volumeRatio":1.234760395021941,"impliedVol":0.0156,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ATRA","defaultTab":"news","newsList":[{"id":"2585147283","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.11%报13.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585147283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585147283?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:35","pubTimestamp":1763735749,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日22时35分,Atara Biotherapeutics, Inc.股票出现异动,股价急速上涨5.11%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。消息层面,截至22时35分,《瑞穗证券维持Atara Biotherapeutics买入评级,上调目标价至18美元》资讯为影响Atara Biotherapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212235499512de89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212235499512de89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2584095943","title":"Atara Biotherapeutics, Inc.2025财年第三财季实现净利润-4.30百万美元,同比增加80.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584095943","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584095943?lang=zh_cn&edition=full","pubTime":"2025-11-18 00:00","pubTimestamp":1763395227,"startTime":"0","endTime":"0","summary":"11月18日,Atara Biotherapeutics, Inc.公布财报,公告显示公司2025财年第三财季净利润为-4.30百万美元,同比增加80.37%;其中营业收入为3.45百万美元,同比减少91.42%,每股基本收益为-0.32美元。从资产负债表来看,Atara Biotherapeutics, Inc.总负债66.80百万美元,其中短期债务11.62百万美元,资产负债比为0.46,流动比率为1.03。机构评级:截至2025年11月18日,当前有3家机构对Atara Biotherapeutics, Inc.目标价做出预测,其中目标均价为16.33美元,其中最低目标价为16.00美元,最高目标价为17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118000040976f316c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118000040976f316c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA"],"gpt_icon":0},{"id":"1146174042","title":"Atara Biotherapeutics预计2025年全年运营费用将比2024年减少至少60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146174042","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146174042?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:05","pubTimestamp":1762956312,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics预计2025年全年运营费用将比2024年减少至少60%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2581012914","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨10.14%报11.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581012914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581012914?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439585,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时33分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅拉升10.14%。截至发稿,该股报11.84美元/股,成交量1148股,换手率0.02%,振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Iovance Biotherapeutics, Inc.、Cytomed Therapeutics Limited、Pharming Group Nv涨幅较大,Osr Holdings, Inc.、Polyrizon Ltd.、Lunai Bioworks Inc.较为活跃,换手率分别为84.31%、11.27%、6.57%,振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Cartesian Therapeutics, Inc.、Sangamo Therapeutics, Inc.,振幅分别为20.60%、11.99%、11.78%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622330594f38150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622330594f38150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"1144783270","title":"Pierre Fabre Pharmaceuticals宣布从Atara Biotherapeutics转让Tabelecleucel治疗EB病毒阳性移植后淋巴增生性疾病的生物许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1144783270","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144783270?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:01","pubTimestamp":1762178505,"startTime":"0","endTime":"0","summary":"Pierre Fabre Pharmaceuticals宣布,从Atara Biotherapeutics转让Tabelecleucel用于治疗EB病毒阳性移植后淋巴增生性疾病(EBV+ PTLD)的生物许可申请(BLA)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2580421782","title":"Atara Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.84%报14.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580421782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580421782?lang=zh_cn&edition=full","pubTime":"2025-11-01 02:37","pubTimestamp":1761935853,"startTime":"0","endTime":"0","summary":"北京时间2025年11月01日02时37分,Atara Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.84%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。其相关个股中,美第奇新星生物技术、Yd Bio Ltd C/Wts 28/08/2030、Rani Therapeutics Holdings, Inc.涨幅较大,Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为1159.68%、375.54%、150.29%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Yd Bio Ltd C/Wts 28/08/2030,振幅分别为155.88%、141.46%、67.65%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110102373394e7d786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110102373394e7d786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2577846380","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577846380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577846380?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:49","pubTimestamp":1761054561,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时49分,Atara Biotherapeutics, Inc.股票出现异动,股价快速跳水6.36%。截至发稿,该股报15.02美元/股,成交量1904股,换手率0.03%,振幅1.81%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Minerva Neurosciences, Inc、Ibio, Inc.、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 涨幅较大,Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃,换手率分别为1019.01%、141.61%、35.12%,振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.,振幅分别为139.02%、78.99%、47.03%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021214921973ac394&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021214921973ac394&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2570031444","title":"Atara Biotherapeutics, Inc.盘中异动 早盘急速上涨5.40%报13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570031444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570031444?lang=zh_cn&edition=full","pubTime":"2025-09-24 21:45","pubTimestamp":1758721533,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日21时45分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.40%。截至发稿,该股报13.67美元/股,成交量1.8392万股,换手率0.26%,振幅4.32%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Uniqure N.V.、Cyclerion Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大,Cyclerion Therapeutics, Inc.、Jaguar Health, Inc.、Uniqure N.V.较为活跃,换手率分别为350.72%、35.43%、30.19%,振幅较大的相关个股有Uniqure N.V.、Pharmacyte Biotech, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为39.90%、28.69%、20.87%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092421453397a7244a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092421453397a7244a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2561486945","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561486945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561486945?lang=zh_cn&edition=full","pubTime":"2025-08-20 21:32","pubTimestamp":1755696752,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日21时32分,Atara Biotherapeutics, Inc.股票出现异动,股价急速上涨5.32%。截至发稿,该股报12.09美元/股,成交量9409股,换手率0.13%,振幅3.32%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Novabay Pharmaceuticals, Inc.、Rocket Pharmaceuticals, Inc.、Propanc Biopharma, Inc.涨幅较大,Novabay Pharmaceuticals, Inc.、Tharimmune, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为1131.27%、506.29%、172.01%,振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Novabay Pharmaceuticals, Inc.、天境生物,振幅分别为27.25%、23.32%、12.07%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820213232a49421df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820213232a49421df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2560816184","title":"Atara Biotherapeutics, Inc.盘中异动 急速下挫5.45%报11.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560816184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560816184?lang=zh_cn&edition=full","pubTime":"2025-08-18 22:05","pubTimestamp":1755525958,"startTime":"0","endTime":"0","summary":"北京时间2025年08月18日22时05分,Atara Biotherapeutics, Inc.股票出现异动,股价快速下跌5.45%。截至发稿,该股报11.62美元/股,成交量9498股,换手率0.14%,振幅6.43%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.、Soligenix, Inc.涨幅较大,Soligenix, Inc.、Aspire Biopharma Holdings, Inc.、Propanc Biopharma, Inc.较为活跃,换手率分别为1614.27%、461.48%、301.20%,振幅较大的相关个股有Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ,振幅分别为125.44%、83.57%、46.26%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818220558a6ed2e34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818220558a6ed2e34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2558667272","title":"Atara Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.52%报10.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558667272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558667272?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:26","pubTimestamp":1754940365,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时26分,Atara Biotherapeutics, Inc.股票出现异动,股价急速跳水5.52%。截至发稿,该股报10.35美元/股,成交量3.2056万股,换手率0.54%,振幅8.90%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.43%。其相关个股中,Equillium, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.涨幅较大,Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为6193.70%、650.16%、534.18%,振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.,振幅分别为84.05%、74.27%、62.69%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812032606a6e016a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812032606a6e016a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2557560458","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.05%报10.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557560458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557560458?lang=zh_cn&edition=full","pubTime":"2025-08-08 00:47","pubTimestamp":1754585237,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日00时47分,Atara Biotherapeutics, Inc.股票出现波动,股价快速下跌5.05%。截至发稿,该股报10.81美元/股,成交量6682股,换手率0.11%,振幅8.52%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大,Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为1764.34%、193.42%、91.72%,振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ,振幅分别为92.00%、82.50%、55.56%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508080047189739fbb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508080047189739fbb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2556440855","title":"Atara Biotherapeutics, Inc.盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556440855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556440855?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:56","pubTimestamp":1753991785,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时56分,Atara Biotherapeutics, Inc.股票出现异动,股价快速下挫5.04%。截至发稿,该股报11.50美元/股,成交量3.3893万股,换手率0.57%,振幅6.74%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.31%。其相关个股中,Soligenix, Inc.、Silexion Therapeutics Corp、Celularity Inc C/Wts 16/07/2026 涨幅较大,Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃,换手率分别为11431.91%、5171.23%、4959.79%,振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为297.60%、97.88%、97.44%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801035625a6cc3277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801035625a6cc3277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2555406780","title":"Atara Biotherapeutics, Inc.盘中异动 大幅拉升5.20%报12.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555406780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555406780?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:20","pubTimestamp":1753885214,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时20分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.20%。截至发稿,该股报12.34美元/股,成交量1.5059万股,换手率0.25%,振幅3.20%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730222014a6c9e4ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730222014a6c9e4ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2555708257","title":"Atara Biotherapeutics, Inc.盘中异动 大幅下挫6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555708257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555708257?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:40","pubTimestamp":1753717241,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时40分,Atara Biotherapeutics, Inc.股票出现异动,股价急速下挫6.22%。截至发稿,该股报10.86美元/股,成交量1.4947万股,换手率0.25%,振幅5.07%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Hyperion Defi, Inc.涨幅较大,Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃,换手率分别为448.76%、244.63%、124.85%,振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为125.48%、82.93%、75.48%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728234041a6c63ce2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728234041a6c63ce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2552741484","title":"Atara Biotherapeutics, Inc.盘中异动 早盘大幅跳水8.08%报8.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552741484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552741484?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:37","pubTimestamp":1752759445,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时37分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅跳水8.08%。截至发稿,该股报8.53美元/股,成交量686股,换手率0.01%,振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Windtree Therapeutics, Inc.、Immuron Limited、Abpro Holdings, Inc较为活跃,换手率分别为536.05%、178.67%、106.11%,振幅较大的相关个股有Windtree Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、知临集团,振幅分别为56.67%、50.00%、20.10%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213725954639a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213725954639a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2551019454","title":"Atara Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551019454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551019454?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:06","pubTimestamp":1752606383,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时06分,Atara Biotherapeutics, Inc.股票出现波动,股价急速下挫5.70%。截至发稿,该股报8.77美元/股,成交量7.4385万股,换手率1.25%,振幅7.98%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.22%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3577.58%、2135.85%、1563.61%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.,振幅分别为444.11%、116.77%、75.50%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603062397a76617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603062397a76617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2550226945","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨5.19%报9.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550226945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550226945?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:07","pubTimestamp":1751994458,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时07分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.19%。截至发稿,该股报9.03美元/股,成交量2.7214万股,换手率0.46%,振幅6.81%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.43%。其相关个股中,Zyversa Therapeutics, Inc.、Seastar Medical Holding Corporation、Rallybio Corporation涨幅较大,Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃,换手率分别为3757.37%、607.49%、338.44%,振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为146.75%、73.81%、70.96%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010738979e946d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010738979e946d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2548159958","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨5.07%报8.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548159958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548159958?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:50","pubTimestamp":1751467819,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时50分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅上涨5.07%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为1868.93%、603.61%、449.39%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings, Inc.,振幅分别为1145.92%、393.59%、96.61%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702225019a72adbee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702225019a72adbee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2544176681","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.24%报7.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544176681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544176681?lang=zh_cn&edition=full","pubTime":"2025-06-20 22:54","pubTimestamp":1750431263,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日22时54分,Atara Biotherapeutics, Inc.股票出现异动,股价急速下跌5.24%。截至发稿,该股报7.60美元/股,成交量1.8266万股,换手率0.31%,振幅5.61%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.88%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大,Nucana Plc、Processa Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为1264.37%、703.53%、337.55%,振幅较大的相关个股有Galectin Therapeutics Inc.、Nucana Plc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为54.97%、47.14%、39.06%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202254239524e3c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202254239524e3c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atarabio.com","stockEarnings":[{"period":"1week","weight":0.2558},{"period":"1month","weight":0.4431},{"period":"3month","weight":0.4847},{"period":"6month","weight":1.0402},{"period":"1year","weight":0.6434},{"period":"ytd","weight":0.352}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。该公司是T细胞免疫疗法的领导者,利用其新型同种异体EB病毒(EBV)T细胞平台为癌症和自身免疫性疾病患者开发转化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.079335},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.062727},{"month":3,"riseRate":0.454545,"avgChangeRate":0.043828},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.039343},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.070861},{"month":6,"riseRate":0.636364,"avgChangeRate":0.068043},{"month":7,"riseRate":0.636364,"avgChangeRate":0.002868},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.029857},{"month":9,"riseRate":0.727273,"avgChangeRate":0.031685},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.093327},{"month":11,"riseRate":0.833333,"avgChangeRate":0.232545},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.068938}],"exchange":"NASDAQ","name":"Atara Biotherapeutics","nameEN":"Atara Biotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atara Biotherapeutics,ATRA,Atara Biotherapeutics股票,Atara Biotherapeutics股票老虎,Atara Biotherapeutics股票老虎国际,Atara Biotherapeutics行情,Atara Biotherapeutics股票行情,Atara Biotherapeutics股价,Atara Biotherapeutics股市,Atara Biotherapeutics股票价格,Atara Biotherapeutics股票交易,Atara Biotherapeutics股票购买,Atara Biotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}